Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Director PRF's Message.

The Journal of the Association of Physicians of India·2026
Same author

A Multispecialty Consensus on Individualized Treatment Strategies for Hypertension Phenotypes and Comorbidities.

The Journal of the Association of Physicians of India·2025
Same author

Prehyperuricemia Deserves More Attention in this Era of Metabolic Explosion: A Review.

The Journal of the Association of Physicians of India·2025
Same author

Community-based approaches to improve tuberculosis services: observations from preintervention and postintervention surveys in a high TB burden disadvantaged community in India.

Thorax·2024
Same author

Position statement on hypertension by Indian Society of Hypertension, 2023.

Journal of human hypertension·2024
Same author

Indian Clinician's Perspective on the Approach to the Management of Hypertension: A Cross-Sectional Study.

Cureus·2024

Related Experiment Video

Updated: Jun 1, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Revised National Tuberculosis Control Programme (RNTCP).

A Muruganathan1, Aleyamma Thomas, M Muniyandi

  • 1Tuberculosis Research Centre (ICMR), Chennai.

Journal of the Indian Medical Association
|June 14, 2011
PubMed
Summary

India faces nearly 2 million annual tuberculosis (TB) cases, compounded by drug resistance. The Directly Observed Treatment Short-course (DOTS) strategy offers a relapse-free cure for TB patients.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Jun 1, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

  • Public Health
  • Infectious Diseases
  • Medical Research

Background:

  • India faces a substantial burden of tuberculosis, with an estimated 1.98 million annual cases.
  • The rise of multidrug-resistant tuberculosis (MDR-TB) poses a significant threat to global public health efforts.
  • Effective control programs are crucial to manage and reduce the incidence of TB.

Purpose of the Study:

  • To outline diagnostic algorithms for pulmonary tuberculosis.
  • To describe the treatment schedules based on patient categorization.
  • To discuss the management of treatment side-effects and the role of the Indian Medical Association (IMA).

Main Methods:

  • Review of diagnostic algorithms for pulmonary tuberculosis.
  • Description of patient categorization for treatment.
  • Narration of treatment schedules and management of side-effects.

Main Results:

  • The article details diagnostic approaches for pulmonary TB.
  • Treatment strategies are presented based on patient groups, including relapse-free cure via DOTS.
  • Management of adverse effects and remedies are discussed.

Conclusions:

  • The Revised National Tuberculosis Control Programme utilizes the Directly Observed Treatment Short-course (DOTS) strategy for effective TB management.
  • Collaboration between the Indian Medical Association (IMA) and the government is vital to decrease the TB disease burden.
  • Comprehensive management including diagnostics, tailored treatment, and side-effect remedies is essential.